San Francisco Sentry Investment Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$281K Sell
1,358
-50
-4% -$10.2K 0.15% 161
2021
Q1
$265K Buy
1,408
+115
+9% +$20.3K 0.11% 189
2020
Q4
$213K Hold
1,293
0.1% 192
2020
Q3
$161K Hold
1,293
0.08% 209
2020
Q2
$126K Buy
1,293
+167
+15% +$17.4K 0.07% 230
2020
Q1
$101K Buy
1,126
+937
+496% +$121K 0.06% 217
2019
Q4
$28K Sell
189
-13
-6% -$1.75K 0.01% 446
2019
Q3
$24K Sell
202
-53
-21% -$6.85K 0.01% 464
2019
Q2
$34K Hold
255
0.02% 417
2019
Q1
$34K Buy
255
+218
+589% +$29.3K 0.01% 437
2018
Q4
$5K Buy
37
+4
+12% +$537 ﹤0.01% 640
2018
Q3
$5K Buy
+33
New +$4.11K ﹤0.01% 661
2018
Q2
Sell
-300
Closed -$29K 785
2018
Q1
$29K Hold
300
0.01% 522
2017
Q4
$26K Sell
300
-18
-6% -$1.45K 0.01% 527
2017
Q3
$25K Sell
318
-2
-0.6% -$161 0.01% 517
2017
Q2
$28K Buy
+320
New +$27.1K 0.01% 419

Other funds holding HCA

San Francisco Sentry Investment Group's HCA Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its HCA Healthcare (HCA) stake by 3.6% in Q2 2021, selling an estimated $10.2K and leaving 1,358 shares worth $281K. The position accounts for 0.15% of the portfolio, ranked #161.

San Francisco Sentry Investment Group first reported a position in HCA in Q2 2017 and has held it in 16 quarters since. 822 funds tracked by Wall St. Rank hold HCA as of Q2 2021.

  • San Francisco Sentry Investment Group held 1,358 shares of HCA Healthcare worth $281K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 50 HCA Healthcare shares in Q2 2021, an estimated $10.2K.
  • HCA Healthcare made up 0.15% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #161 holding.
  • San Francisco Sentry Investment Group first reported a position in HCA Healthcare in Q2 2017 and has held it in 16 quarters since.
  • 822 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.